Top Markets
#1 GEKKO GEKKO +52.86%
#2 ADO Protocol ADO Protocol +38.61%
#3 Pons Pons +38.26%
#4 Prom Prom +32.61%
#5 Helium Helium +29.77%
#6 CZ'S Dog CZ'S Dog +21.03%
#7 龙虾 (Lobster) 龙虾 (Lobster) +19.96%
#8 TENDIES TENDIES +19.66%
#9 Main Street Yield Main Street Yield +17.48%
#10 OpenGradient OpenGradient +17.07%
Coin of the day
GEKKO GEKKO
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Kolon TissueGene, Inc. Kolon TissueGene, Inc.

Kolon TissueGene, Inc.

950160
Peringkat dalam Saham #9085
Kolon TissueGene, Inc. is a biopharmaceutical firm specializing in the... Kolon TissueGene, Inc. is a biopharmaceutical firm specializing in the advancement of clinical-stage cell-based treatments for osteoarthritis. Its flagship offering is TG-C, a proprietary platform technology that integrates allogeneic primary cells with genetically engineered counterparts. Established by Kwan H. Lee on June 9, 1999, the enterprise maintains its corporate headquarters in Rockville, Maryland.
Harga Saham
$12.94
Terakhir disinkronkan: 2026-08-28
Kapitalisasi Pasar
$1.10B
Perubahan (1 hari)
-0.16%
Perubahan (1 tahun)
-51.50%
Negara
US
Perdagangan Kolon TissueGene, Inc. (950160)

Kategori

Healthcare
Riwayat hasil dividen untuk Kolon TissueGene, Inc. (950160)
Hasil dividen (TTM) dari Kolon TissueGene, Inc. (simbol saham: 950160) per 2026: 0
Rata-rata hasil dividen selama 5 tahun terakhir: 0.00%
Riwayat hasil dividen untuk Kolon TissueGene, Inc. (950160) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Hasil dividen (TTM) untuk perusahaan serupa atau pesaing
Perusahaan Hasil Dividen Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH